Tax Credit For Industry/Academia Research Could Be Backed By Rep. Archer
Legislation to create tax incentives for pharmaceutical companies to conduct clinical research at academic institutions could be proposed by House Ways & Means Committee Chairman Archer (R-Tex.) if the provision is not included in the comprehensive managed health care bill that emerges from conference.
You may also be interested in...
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth